Schrodinger, Inc.

SDGR · Healthcare

$20.84

Capitalizzazione: 1.56B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Schrodinger, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

Zacks3 set 2026, 14:32

Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook?

CNW Group3 set 2026, 12:55

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

Business Wire1 set 2026, 12:30

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Zacks18 ago 2026, 07:43

The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci

Zacks17 ago 2026, 13:56

4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma